Walleye Capital LLC Eli Lilly & CO Transaction History

Walleye Capital LLC

$46.2 Billion
Q3 2024

A detailed history of Walleye Capital LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Walleye Capital LLC holds 73,200 shares of LLY stock, worth $55.1 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

73,200

Previous 49,700 47.28%

Holding current value

$55.1 Million

Previous $45 Million 44.12%

% of portfolio

0.14%

Previous 0.08%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $26.4 Million - $32.8 Million	34,164 Added 181.35%	53,003 $47 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $832,150 - $1.04 Million	1,148 Added 6.49%	18,839 $17.1 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $2.72 Million - $3.64 Million	4,599 Added 35.13%	17,691 $13.8 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $6.88 Million - $8.11 Million	13,092 New	13,092 $7.63 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $30.3 Million - $40.5 Million	-86,350 Reduced 99.6%	348 $163,000
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $26.9 Million - $31.6 Million	86,698 New	86,698 $29.8 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $2.1 Million - $2.39 Million	7,075 Added 128.03%	12,601 $4.08 Million
Q2 2022 Aug 08, 2022	BUY	$278.73 - $327.27 $1.54 Million - $1.81 Million	5,526 New	5,526 $1.79 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $5.2 Million - $6.47 Million	-22,167 Closed	0 $0
Q4 2021 Mar 03, 2022	BUY	$224.85 - $279.04 $4.98 Million - $6.19 Million	22,167 New	22,167 $6.12 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $3.68 Million - $4.52 Million	-16,592 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $1.81 Million - $2.35 Million	-10,052 Reduced 37.73%	16,592 $3.81 Million
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $1.24 Million - $1.61 Million	7,547 Added 39.52%	26,644 $4.98 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $2.37 Million - $3.13 Million	18,137 Added 1889.27%	19,097 $3.22 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $63,082 - $78,133	590 Added 159.46%	960 $126,000
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $18,834 - $21,984	170 Added 85.0%	370 $41,000
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $22,262 - $26,204	200 New	200 $26,000

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Account

Walleye Capital LLC Eli Lilly & CO Transaction History